InvestorsHub Logo
Followers 237
Posts 10817
Boards Moderated 0
Alias Born 07/17/2006

Re: ilovetech post# 279783

Friday, 06/12/2020 3:10:21 PM

Friday, June 12, 2020 3:10:21 PM

Post# of 423920
Ilove...

PCPs and other clinicians are up to their eyebrows in paperwork and computers..A clinician might be willing to write a letter to a drug plan to try to get a lower script cost for a patient..There was a time when drug plans might honor the request..But more than ever drug plans are pushing back..Insurance companies can usually out muscle any opposition..or out stall them or just ignore them..Insurance companies have personnel whose job is just to do that..

As I noted earlier insurance companies can be very dumb when it comes to their actions..but their actions usually end up bolstering their bottom line..

I think the fact Teva took a settlement (and a relatively cheap one) says a lot about how much the Marine indication is worth..They have to know the Lovaza vs Vascepa story better than most...Teva is one of the sharper knives in the drawer...I would not shed too many tears about Amarin losing on the Marine label...The real money is the R-I indication and currently there is no alternative for that..

The sell off is way over done..Be patient the PPS will be coming back..

IMO Amarin has not lost very much..

":>) JL
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News